Type to search

News Stuff

Scientist behind Incyte’s Jakafi ready to expand

Share

A founding scientist and previous vice president of the pharmaceutical company Incyte is growing his next venture in Delaware.

The state Council on Development Finance (CDF) voted Monday to recommend a performance-based grant package for Prelude Therapeutics. The company was launched by Kris Vaddi in July 2016, with the aim of creating a leading cancer drug discovery-based biotech company.

With assistance from the Delaware Division of Small Business, Development & Tourism, company officials said they plan to add around 30 staff members and move to a new, larger location in Delaware.

“There’s certainly the pressure of expectations, but we are driven by science and the possibility of making a difference in cancer care,” said Vaddi. “If you do good science with clear goals, the rest will happen. I truly hope we can create the next successful biotech company for Delaware.”

Get the free DBT email newsletter  

Follow the people, companies and issues that matter most to business in Delaware.

Tags:

You Might also Like

Leave a Comment

Your email address will not be published. Required fields are marked *

Get the DBT Book of Lists

The definitive publication of contacts and key information from over 1,500 of Delaware's top businesses and organizations across 60 industries. 

No, thank you.

Free for a limited time! (Normally $50)

Stay updated with our free email newsletter

Keep up with the issues, companies and people that matter most to business in Delaware.

No, thank you.